LICENSING

Innovative leadership guides licensing decisions.

Our Licensing leadership team understands both the science and business aspects of each partnership. Each leader brings energy and an entrepreneurial spirit to our licensing efforts. We offer flexibility and creativity in negotiations and focus on forging a customized agreement that meets your unique needs and helps bring your discovery to fruition so that all involved may benefit.

"Merck is an innovation company. I strongly believe that combining forces with partners who share our passion for science allows us to create even more value for patients and shareholders alike."

Roger J. Pomerantz, MD, FACP
Senior Vice President
Worldwide Licensing & Acquisitions

"Licensing is a key to Merck's future. Currently, a significant amount of Merck's revenue is generated from licensed-in products and patents. We expect this to continue to grow as we vigorously pursue external partnerships."

Richard N. Kender, MBA
Senior Vice President
Business Development and Corporate Licensing

"Flexibility and creativity are critical components of our negotiation process. We're interested in listening to you, to find the best way to bring your discovery through development to market."

Barbara Yanni, JD, LLM, CLP
Vice President and Chief Licensing Officer

"Merck's scientists recognize that 99 percent of all discovery activity occurs outside of the company's walls, and that it is a critical component of their roles to pay attention to what is going on throughout the world in their areas of expertise. They are charged with bringing the best compound forward, irrespective of whether it is identified at their bench or comes from the outside via a licensing arrangement."

Greg Wiederrecht, PhD, CLP
Vice President and Head
External Scientific Affairs

• Print
• Share
• Text Size
• Access